Objective Epidemiologic data on falls in the population with systemic lupus erythematosus (SLE) remain sparse. We estimated ...
Objectives To estimate the risk of venous thromboembolism (VTE) in a nationwide cohort of newly diagnosed patients with SLE ...
Objective Belimumab has been proven to be effective for treating refractory lupus nephritis. However, the meaningful renal ...
Objectives CD163 is a macrophage-associated scavenger receptor shed during inflammatory activation, resulting in measurable ...
Objective Childhood-onset SLE (cSLE) is often described as more severe than adult-onset disease (aSLE) based largely on cross ...
Objective A data-driven and expert/patient consensus-based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index ...
Objective To determine whether circulating kidney injury molecule-1 (KIM-1) predicts long-term renal outcomes in lupus nephritis (LN), including relapse, progression to end-stage kidney disease (ESKD) ...
Objectives To determine the prevalence of cerebral atrophy in a multi-ethnic systemic lupus erythematosus (SLE) cohort and to identify its associated clinical factors. Methods In this cross-sectional ...
Objective Autoimmune haemolytic anaemia (AIHA) occurs in approximately 5–10% of patients with SLE and it is traditionally associated with higher disease activity, increased damage accrual and reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results